Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Gains from Investment Securities data on file, last reported at -$24.8 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at -$24.8 million, down 825633.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1000.0 (up 100.08% YoY), and the FY2024 annual result was -$994000.0, up 83.19% from the prior year.
• Gains from Investment Securities retreated to -$24.8 million in Q1 2026 per TWST's latest filing, from $24.8 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $24.8 million in Q4 2025 and troughed at -$24.8 million in Q1 2026.
• A 5-year average of -$1.4 million and a median of -$444000.0 in 2022 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities soared 825666.67% in 2025, then tumbled 825633.33% in 2026.
• A 5-year view of Gains from Investment Securities shows it stood at $52000.0 in 2022, then tumbled by 676.92% to -$300000.0 in 2023, then soared by 101.0% to $3000.0 in 2024, then soared by 825666.67% to $24.8 million in 2025, then sank by 200.0% to -$24.8 million in 2026.
• Business Quant data shows TWST's Gains from Investment Securities at -$24.8 million in Q1 2026, $24.8 million in Q4 2025, and -$603000.0 in Q3 2025.